Equity IPO Brazil
Brazilian medical supplies company raises $370 mln in second IPO attempt
Corporate & Sovereign Strategy Debt Fixed Income
Argentine pharmaceutical company seeks to raise up to $85 mln through a financial trust
Equity Healthcare Pharmaceuticals
Colombian vaccination company will use $54 mln from Sura to build a production plant, but it could need more investments for later stages, CEO says
M&A Healthcare Pharmaceuticals
Brazilian drugmaker agrees to spend $190 mln for 12 OTC and prescription brands in Brazil, Mexico and Colombia
M&A Equity Pharmaceuticals
Brazilian drugstore chain strikes a $133 mln deal to become the second largest company in the sector
Brazilian drugstore chain could form the second largest company in the sector if it seals a deal with local conglomerate Ultrapar
M&A Equity Funds
US private equity firm will combine the acquired operations with Mexican drug maker Somar and form a company with $177 mln in revenues
Debt Fixed Income Pharmaceuticals
Argentine pharmaceutical company to raise up to $70 mln through a green trust instrument
Funds M&A ESG
Brazilian investment firm has $176 mln to buy stakes in companies with "clear" ESG goals
Corporate & Sovereign Strategy Equity IPO
Brazilian tech support company joins the rush to the B3, while drug maker sets a target range for its offering